Viewing StudyNCT00002059



Ignite Creation Date: 2024-05-05 @ 11:08 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00002059
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02

Brief Title: A Double-Blind Placebo Controlled Study To Determine the Optimal Immunopharmacological Dose Level of Isoprinosine in Immunodepressed Volunteers
Sponsor: Newport Pharmaceuticals International
Organization: NIH AIDS Clinical Trials Information Service

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
AIDS-Related Complex View
T-Lymphocytes Suppressor-Effector View
Neoplasms View
Inosine Pranobex View
Killer Cells View
T-Lymphocytes Helper-Inducer View
Acquired Immunodeficiency Syndrome View